Suchergebnisse - "Kanno, Yoshihiko"

PubPharm (286)

41

Comparisons of Clinical Outcomes in Patients Transferred to Combined Therapy with Peritoneal Dialysis and Hemodialysis over those Directly Transferred to Hemodialysis: A Prospective Multicenter Study in Japan

enthalten in: ResearchSquare.com | 2021

von Maruyama, Y. | Yokoyama, K. | Higuchi, C. | +8

42

Blood pressure management in patients receiving renal replacement therapy

enthalten in: Hypertension research : official journal of the Japanese Society of Hypertension | 2021

von Kanno, Y.

43

Survival and predictive factors in dialysis patients with COVID-19 in Japan : a nationwide cohort study

enthalten in: Renal replacement therapy | 2021

von Kikuchi, K. | Nangaku, M. | Ryuzaki, M. | +10

44

Long-Term Safety and Effectiveness of the Xanthine Oxidoreductase Inhibitor, Topiroxostat in Japanese Hyperuricemic Patients with or Without Gout : A 54-week Open-label, Multicenter, Post-marketing Observational Study

enthalten in: Clinical drug investigation | 2020

von Ishikawa, T. | Maeda, T. | Hashimoto, T. | +4

45

Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model

enthalten in: BMC pharmacology & toxicology | 2020

von Morita, S. | Shinoda, K. | Yoshida, T. | +8

46

Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model

enthalten in: BMC pharmacology & toxicology | 2020

von Morita, S. | Shinoda, K. | Yoshida, T. | +8

47

Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model

enthalten in: BMC pharmacology & toxicology | 2020

von Morita, S. | Shinoda, K. | Yoshida, T. | +8

48

We can have it all, but we just cannot have it all at once

enthalten in: Hypertension research : official journal of the Japanese Society of Hypertension | 2020

von Kanno, Y.

CommentOn: Hypertens Res. 2020 Aug;43(8):791-797. - PMID 32203454

49

COVID-19 of dialysis patients in Japan : Current status and guidance on preventive measures

enthalten in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | 2020

von COVID-19 Task Force Committee of the Japanese Association of Dialysis Physicians | Japanese Society for Dialysis Therapy | Japanese Society of Nephrology | +11

50

Long-Term Safety and Effectiveness of the Xanthine Oxidoreductase Inhibitor, Topiroxostat in Japanese Hyperuricemic Patients with or Without Gout: A 54-week Open-label, Multicenter, Post-marketing Observational Study

enthalten in: Clinical drug investigation | 2020

von Ishikawa, T. | Maeda, T. | Hashimoto, T. | +4